Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study.
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-beta.
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome.
Plasma Exchange for Steroid-Refractory Relapses in Multiple Sclerosis: An Observational, MRI Pilot Study.
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.
Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
A rare brain infection with multiple sclerosis dug.
Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report.
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.
Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients.
Clinical Relevance of Serum Aquaporin-4 Antibody Levels in Neuromyelitis Optica.
Ocular motor signatures of cognitive dysfunction in multiple sclerosis.
Vaccination, infection, and the risk for multiple sclerosis.
Neuromyelitis optica spectrum disorders without and with autoimmune diseases.
Stem cell therapy in multiple sclerosis: a future perspective.
Functional neuroimaging may quantify spinal cord demyelinating disease.
Visual field impairment captures disease burden in multiple sclerosis.
Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes.

Pages